BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 28416003)

  • 1. Characterization and risk estimate of cancer in patients with primary Sjögren syndrome.
    Brito-Zerón P; Kostov B; Fraile G; Caravia-Durán D; Maure B; Rascón FJ; Zamora M; Casanovas A; Lopez-Dupla M; Ripoll M; Pinilla B; Fonseca E; Akasbi M; de la Red G; Duarte-Millán MA; Fanlo P; Guisado-Vasco P; Pérez-Alvarez R; Chamorro AJ; Morcillo C; Jiménez-Heredia I; Sánchez-Berná I; López-Guillermo A; Ramos-Casals M;
    J Hematol Oncol; 2017 Apr; 10(1):90. PubMed ID: 28416003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphoma and other malignancies in primary Sjögren's syndrome: a cohort study on cancer incidence and lymphoma predictors.
    Theander E; Henriksson G; Ljungberg O; Mandl T; Manthorpe R; Jacobsson LT
    Ann Rheum Dis; 2006 Jun; 65(6):796-803. PubMed ID: 16284097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic activity and mortality in primary Sjögren syndrome: predicting survival using the EULAR-SS Disease Activity Index (ESSDAI) in 1045 patients.
    Brito-Zerón P; Kostov B; Solans R; Fraile G; Suárez-Cuervo C; Casanovas A; Rascón FJ; Qanneta R; Pérez-Alvarez R; Ripoll M; Akasbi M; Pinilla B; Bosch JA; Nava-Mateos J; Díaz-López B; Morera-Morales ML; Gheitasi H; Retamozo S; Ramos-Casals M;
    Ann Rheum Dis; 2016 Feb; 75(2):348-55. PubMed ID: 25433020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cryoglobulinaemic vasculitis at diagnosis predicts mortality in primary Sjögren syndrome: analysis of 515 patients.
    Retamozo S; Gheitasi H; Quartuccio L; Kostov B; Corazza L; Bové A; Sisó-Almirall A; Gandía M; Ramos-Casals M; De Vita S; Brito-Zerón P
    Rheumatology (Oxford); 2016 Aug; 55(8):1443-51. PubMed ID: 27107430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hematologic manifestations and predictors of lymphoma development in primary Sjögren syndrome: clinical and pathophysiologic aspects.
    Baimpa E; Dahabreh IJ; Voulgarelis M; Moutsopoulos HM
    Medicine (Baltimore); 2009 Sep; 88(5):284-293. PubMed ID: 19745687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of B cell lymphoma in patients with Sjögren's syndrome and hepatitis C virus infection.
    Ramos-Casals M; la Civita L; de Vita S; Solans R; Luppi M; Medina F; Caramaschi P; Fadda P; de Marchi G; Lopez-Guillermo A; Font J;
    Arthritis Rheum; 2007 Feb; 57(1):161-70. PubMed ID: 17266090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting the outcome of Sjogren's syndrome-associated non-hodgkin's lymphoma patients.
    Papageorgiou A; Ziogas DC; Mavragani CP; Zintzaras E; Tzioufas AG; Moutsopoulos HM; Voulgarelis M
    PLoS One; 2015; 10(2):e0116189. PubMed ID: 25723713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Gougerot-Sjögren syndrome. Risk of lymphoma].
    Mariette X
    Presse Med; 1999 Jun; 28(22):1214-8. PubMed ID: 10414252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of cancer in a cohort of patients with primary Sjogren's syndrome.
    Lazarus MN; Robinson D; Mak V; Møller H; Isenberg DA
    Rheumatology (Oxford); 2006 Aug; 45(8):1012-5. PubMed ID: 16490754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognosis and outcome of non-Hodgkin lymphoma in primary Sjögren syndrome.
    Voulgarelis M; Ziakas PD; Papageorgiou A; Baimpa E; Tzioufas AG; Moutsopoulos HM
    Medicine (Baltimore); 2012 Jan; 91(1):1-9. PubMed ID: 22198497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The risk of cancer in patients with primary Sjögren syndrome: a single-center study from Turkey.
    Aslan B; Öğüt TS; Erbasan F; Dilbil M; Çelik E; Terzioğlu ME; Yazısız V
    Turk J Med Sci; 2022 Jun; 52(3):587-595. PubMed ID: 36326315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mortality risk factors in primary Sjögren syndrome: a real-world, retrospective, cohort study.
    Brito-Zerón P; Flores-Chávez A; Horváth IF; Rasmussen A; Li X; Olsson P; Vissink A; Priori R; Armagan B; Hernandez-Molina G; Praprotnik S; Quartuccio L; Inanç N; Özkızıltaş B; Bartoloni E; Sebastian A; Romão VC; Solans R; Pasoto SG; Rischmueller M; Galisteo C; Suzuki Y; Trevisani VFM; Fugmann C; González-García A; Carubbi F; Jurcut C; Shimizu T; Retamozo S; Atzeni F; Hofauer B; Melchor-Díaz S; Gheita T; López-Dupla M; Fonseca-Aizpuru E; Giacomelli R; Vázquez M; Consani S; Akasbi M; Nakamura H; Szántó A; Farris AD; Wang L; Mandl T; Gattamelata A; Kilic L; Pirkmajer KP; Abacar K; Tufan A; de Vita S; Bootsma H; Ramos-Casals M;
    EClinicalMedicine; 2023 Jul; 61():102062. PubMed ID: 37457113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk, predictors, and clinical characteristics of lymphoma development in primary Sjögren's syndrome.
    Solans-Laqué R; López-Hernandez A; Bosch-Gil JA; Palacios A; Campillo M; Vilardell-Tarres M
    Semin Arthritis Rheum; 2011 Dec; 41(3):415-23. PubMed ID: 21665245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of cancer in a nationwide population cohort of 7852 patients with primary Sjogren's syndrome in Taiwan.
    Weng MY; Huang YT; Liu MF; Lu TH
    Ann Rheum Dis; 2012 Apr; 71(4):524-7. PubMed ID: 22072014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Rituximab therapy for systemic manifestations and MALT lymphomas of the parotid gland in Sjögren's disease: preliminary data].
    Logvinenko OA; Vasil'ev VI; Sedyshev SKh; Safonova TN; Rodionova EB; Kokosadze NV; Aleksandrova EN; Cherkasova MV; Radenska-Lopovok SG; Nasonov EL
    Ter Arkh; 2012; 84(12):88-96. PubMed ID: 23479998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [MALT-lymphomas in Sjogren's disease].
    Vasil'ev VI; Probatova NA; Tupitsin NN; Varlamova EIu; Logvinenko OA; Rodionova EB; Kovrigina AM; Kokosadze NV; Panin MG; Gaĭduk IV; Gorbunova TV; Kondrat'eva TT; Sholokhova EN; Simonova MV; Safonova TN; Radenska-Lopovok SG
    Ter Arkh; 2006; 78(1):45-52. PubMed ID: 16512445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary Sjögren's syndrome is associated with increased risk of malignancies besides lymphoma: A systematic review and meta-analysis.
    Zhong H; Liu S; Wang Y; Xu D; Li M; Zhao Y; Zeng X
    Autoimmun Rev; 2022 May; 21(5):103084. PubMed ID: 35341972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hematologic malignancies in patients with cryoglobulinemia: association with autoimmune and chronic viral diseases.
    Trejo O; Ramos-Casals M; López-Guillermo A; García-Carrasco M; Yagüe J; Cervera R; Font J; Ingelmo M
    Semin Arthritis Rheum; 2003 Aug; 33(1):19-28. PubMed ID: 12920693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Other cancers in patients with gastric MALT lymphoma.
    Montalbàn C; Castrillo JM; López-Abente G; Abraira V; Serrano M; Bellas C; Piris MA; Carrion R; Cruz MA; García-Laraña J; Menarguez J; Rivas C
    Leuk Lymphoma; 1999 Mar; 33(1-2):161-8. PubMed ID: 10194134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A clinical prediction rule for lymphoma development in primary Sjögren's syndrome.
    Baldini C; Pepe P; Luciano N; Ferro F; Talarico R; Grossi S; Tavoni A; Bombardieri S
    J Rheumatol; 2012 Apr; 39(4):804-8. PubMed ID: 22337248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.